Screener
Gilead Sciences GILD Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $172.99B.
The source filing: Gilead Sciences’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000882095-26-000024
FAQ
- What is Gilead Sciences's market capitalization?
- Gilead Sciences (GILD) reported market capitalization of $172.99B in Q1 2026.
- How has Gilead Sciences's market capitalization changed year-over-year?
- Gilead Sciences's market capitalization increased by 23.8% year-over-year, from $139.69B to $172.99B.
- What is the long-term trend for Gilead Sciences's market capitalization?
- Over 5 years (2020 to 2025), Gilead Sciences's market capitalization has grown at a 15.8% compound annual growth rate (CAGR), from $73.08B to $152.28B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Gilead Sciences's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude